Natixis Advisors LLC boosted its position in Stride, Inc. (NYSE:LRN - Free Report) by 47.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 181,910 shares of the company's stock after buying an additional 58,487 shares during the period. Natixis Advisors LLC owned approximately 0.42% of Stride worth $15,518,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Crossmark Global Holdings Inc. boosted its holdings in Stride by 3.9% during the third quarter. Crossmark Global Holdings Inc. now owns 3,213 shares of the company's stock worth $274,000 after purchasing an additional 121 shares during the last quarter. SummerHaven Investment Management LLC lifted its stake in shares of Stride by 1.1% during the 2nd quarter. SummerHaven Investment Management LLC now owns 20,454 shares of the company's stock valued at $1,442,000 after buying an additional 217 shares in the last quarter. Arizona State Retirement System increased its holdings in Stride by 1.9% during the 2nd quarter. Arizona State Retirement System now owns 11,536 shares of the company's stock worth $813,000 after acquiring an additional 220 shares during the period. Isthmus Partners LLC increased its holdings in Stride by 4.8% during the 2nd quarter. Isthmus Partners LLC now owns 4,814 shares of the company's stock worth $339,000 after acquiring an additional 222 shares during the period. Finally, Amalgamated Bank increased its holdings in shares of Stride by 1.9% in the 3rd quarter. Amalgamated Bank now owns 12,528 shares of the company's stock worth $1,069,000 after buying an additional 235 shares during the last quarter. 98.24% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several equities research analysts have weighed in on LRN shares. Citigroup increased their price target on shares of Stride from $90.00 to $94.00 and gave the company a "neutral" rating in a research report on Tuesday, October 29th. BMO Capital Markets raised their price objective on shares of Stride from $84.00 to $88.00 and gave the company an "outperform" rating in a research note on Thursday, October 24th. Canaccord Genuity Group assumed coverage on shares of Stride in a research note on Thursday, August 8th. They issued a "buy" rating and a $94.00 price target for the company. StockNews.com downgraded shares of Stride from a "buy" rating to a "hold" rating in a report on Wednesday, October 23rd. Finally, Canaccord Genuity Group raised their price objective on shares of Stride from $94.00 to $100.00 and gave the stock a "buy" rating in a report on Wednesday, October 23rd. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Stride presently has an average rating of "Moderate Buy" and a consensus target price of $90.17.
Read Our Latest Research Report on LRN
Stride Trading Up 1.1 %
Shares of NYSE:LRN traded up $1.09 during midday trading on Wednesday, reaching $102.75. 215,339 shares of the company's stock were exchanged, compared to its average volume of 836,214. The stock has a market cap of $4.48 billion, a price-to-earnings ratio of 18.48, a P/E/G ratio of 0.75 and a beta of 0.27. The company has a debt-to-equity ratio of 0.38, a current ratio of 5.60 and a quick ratio of 5.50. The firm's 50 day simple moving average is $85.37 and its two-hundred day simple moving average is $77.41. Stride, Inc. has a fifty-two week low of $54.81 and a fifty-two week high of $103.98.
Stride (NYSE:LRN - Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.22 by $0.72. The firm had revenue of $551.08 million during the quarter, compared to the consensus estimate of $504.29 million. Stride had a return on equity of 21.23% and a net margin of 11.38%. The firm's quarterly revenue was up 14.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.11 earnings per share. As a group, sell-side analysts forecast that Stride, Inc. will post 6.66 EPS for the current fiscal year.
Insider Transactions at Stride
In other Stride news, Director Todd Goldthwaite sold 8,028 shares of the company's stock in a transaction on Friday, October 25th. The stock was sold at an average price of $91.54, for a total value of $734,883.12. Following the sale, the director now owns 85,058 shares of the company's stock, valued at approximately $7,786,209.32. This represents a 8.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 3.00% of the company's stock.
About Stride
(
Free Report)
Stride, Inc, a technology-based education service company, engages in the provision of proprietary and third-party online curriculum, software systems, and educational services in the United States and internationally. Its technology-based products and services enable clients to attract, enroll, educate, track progress, support, and facilitate individualized learning for students.
Further Reading
Before you consider Stride, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stride wasn't on the list.
While Stride currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.